Location: | London |
---|---|
Salary: | £36,274 to £52,090 per annum, including London Weighting Allowance |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 7th December 2022 |
---|---|
Closes: | 4th January 2023 |
Job Ref: | 059109 |
Job description
This is an exciting new position where the successful candidate will have the opportunity to work as part of an internationally leading team of researchers investigating cannabinoid-based treatments for neurodegenerative and psychiatric disorders and play a key role in a new line of research investigating the safety, efficacy and mechanism of action of a novel cannabinoid-based pharmacological treatment for Parkinson’s disease psychosis. As part of this role, the appointed person will be directly involved in a multi-centre Parkinson’s UK funded randomised clinical trial to evaluate this new pharmacological treatment for people with Parkinson’s disease and Psychosis. While the person will be based in the Academic Psychiatry Division of IoPPN at KCL for administrative purposes and will work closely with the Lead PI for this study, Prof Sagnik Bhattacharyya (https://www.kcl.ac.uk/people/professor-sagnikbhattacharyya) they will also work with other investigators based at King’s College London, in particular Prof K Ray Chaudhuri (http://parkinsons-london.co.uk/centre-of-excellence-in-parkinsons-and-movement-disorders/research-team/ray-chaudhuri/), and with investigators based in the Old Age Psychiatry department at King’s College London.
This post is currently funded for 18 months with potential for 6 months extension and an anticipated start from February/March 2023. However, the start date is flexible and may be negotiated with the right candidate, especially if the selected candidate needs additional time to obtain necessary approvals.
The successful applicant will play a key role in the assessment and monitoring of patients with Parkinson’s disease taking part in the study and along with a team of researchers will contribute to the collection and recording of clinical trial and neuroimaging data. The appointed person will work as part of a larger group of researchers for this multi-site clinical trial.
Candidates should be highly motivated individuals with excellent communication skills, the ability to work independently as well as part of a team, and capacity to apply sound clinical knowledge and judgement.
Fluency in English, both oral and written, is essential.
The post holder will be a clinician (Psychiatrist or Neurologist or Geriatrician) with some clinical experience but may not have finished their specialist clinical training. Those with experience and/or interest in Parkinson’s disease and/or other neurodegenerative disorders are particularly welcome. It would also suit a medical doctor with previous experience of research who may want to spend a period of time in research before getting into clinical training. In general, it would suit a clinician with an interest in psychopharmacology, neuroimaging and psychosis.
This post will be offered on an a fixed-term contract for 18 months
This is a full-time post - 100% full time equivalent
Type / Role:
Subject Area(s):
Location(s):